Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.707,91
0,34%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Day One Biopharmaceuticals Inc (DAWN) Day One Biopharmaceuticals Inc (DAWN) Notizie

DAWN

Day One Biopharmaceuticals (DAWN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DAWN
DataOraFonteTitoloSimboloCompagnia
30/05/202414:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
29/05/202400:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
17/05/202400:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
06/05/202422:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DAWNDay One Biopharmaceuticals Inc
04/01/202422:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DAWNDay One Biopharmaceuticals Inc
30/10/202315:54Dow Jones NewsDay One Biopharmaceuticals Shares Rally on FDA Priority ReviewNASDAQ:DAWNDay One Biopharmaceuticals Inc
30/10/202313:58Dow Jones NewsDay One Gets FDA Priority Review of Tovorafenib in Pediatric Brain TumorNASDAQ:DAWNDay One Biopharmaceuticals Inc
20/10/202322:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/09/202323:28Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:DAWNDay One Biopharmaceuticals Inc
27/06/202301:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DAWNDay One Biopharmaceuticals Inc
23/06/202322:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAWNDay One Biopharmaceuticals Inc
12/06/202322:13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DAWNDay One Biopharmaceuticals Inc
08/06/202313:00PR Newswire (US)KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMANASDAQ:DAWNDay One Biopharmaceuticals Inc
07/06/202322:58Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:DAWNDay One Biopharmaceuticals Inc
05/06/202322:50Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:DAWNDay One Biopharmaceuticals Inc
01/05/202315:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DAWNDay One Biopharmaceuticals Inc
28/04/202322:12Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DAWNDay One Biopharmaceuticals Inc
28/04/202322:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/02/202322:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/02/202300:21Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:DAWNDay One Biopharmaceuticals Inc
09/01/202319:16Dow Jones NewsDay One Biopharma Shares Rise 13% After Positive Topline Results for TovorafenibNASDAQ:DAWNDay One Biopharmaceuticals Inc
10/11/202213:15TipRanksJ.P. Morgan Sticks to Their Buy Rating for Day One Biopharmaceuticals (DAWN)NASDAQ:DAWNDay One Biopharmaceuticals Inc
08/11/202214:55TipRanksJonesTrading Reaffirms Their Buy Rating on Day One Biopharmaceuticals (DAWN)NASDAQ:DAWNDay One Biopharmaceuticals Inc
31/10/202221:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/09/202217:05TipRanksJonesTrading Remains a Buy on Day One Biopharmaceuticals (DAWN)NASDAQ:DAWNDay One Biopharmaceuticals Inc
12/09/202217:14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DAWNDay One Biopharmaceuticals Inc
05/09/202223:15TipRanksDay One Biopharmaceuticals (DAWN) Receives a Buy from JonesTradingNASDAQ:DAWNDay One Biopharmaceuticals Inc
24/06/202201:26TipRanksInsiders Go All-In on These 2 ‘Strong Buy’ StocksNASDAQ:DAWNDay One Biopharmaceuticals Inc
23/06/202214:54TipRanksThis Top Insider Just Increased Its Appetite for DAWN StockNASDAQ:DAWNDay One Biopharmaceuticals Inc
14/06/202223:42TipRanksDay One Stock Is up 139% This Week. How Much Higher Can It Go?NASDAQ:DAWNDay One Biopharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DAWN

La tua Cronologia

GATE
IONXETH
Charged Particles - IONX
BIT
IRE
Iren
BIT
VOW3
Volkswagen
BIT
P1H4Q2
BNP Paribas Issuance
BIT
I05620
Banca IMI
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network